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Background: Glucose regulated protein 78 (Grp78) is involved in the invasion and metastasis in many human
cancers including gastric cancer, breast cancer, prostate cancer. But the role of Grp78 in the invasion of human
hepatocellular carcinoma has not been reported. In this article, we examined if Grp78 was associated with the
invasion of hepatocellular carcinoma and explored the possible underlying mechanism.
Methods: The Grp78 and FAK expression levels in 44 patients with hepatocellular carcinoma were examined using
immunohistochemistry. Grp78 overexpressing SMMC7721 cells were established by pcDNA3.1 (+)-Grp78
transfection and screened by G418. Grp78 and FAK levels in Grp78 overexpressing cells were down-regulated by
siRNA transfection. The invasion status of tumor cells was evaluated by transwell assay in vitro, and chick embryo
metastasis model in vivo. Cell spreading was determined by cell spreading assay, and quantitatively measured by
Orisis software HUG. Grp78, pY397 FAK, pY576/577 FAK and FAK levels were detected by western blot. RhoA
activity was detected by GST pulldown assay. The distribution of actin cytoskeleton was observed by fluorescent
staining.
Results: Grp78 expression levels in 44 patients with hepatocellular carcinoma were negatively correlated with
tumor grading, and positively correlated with portal invasion and intra-hepatic invasion. Overexpression of Grp78 in
SMMC7721 cells promoted the invasion of cancer cells in vitro and in vivo, and this increase in tumor cell invasion
was blocked by Grp78 siRNA knockdown. Our results also revealed that overexpression of Grp78 in SMMC7721 cells
accelerated the process of cell spreading and promoted lamellipodia formation. Further analysis showed that
overexpression of Grp78 in SMMC7721 cells increased pY397 and pY576/577 levels of FAK. Grp78 siRNA
knockdown decreased FAK activation and activity. Our results also revealed that Grp78 overexpression in
SMMC7721 cells decreased RhoA-GTP level, and Grp78 siRNA knockdown rescued RhoA-GTP level in Grp78
overexpressing cells, indicating Grp78 inhibited RhoA activity in hepatocellular carcinoma cells. Furthermore,
overexpression of Grp78 in SMMC7721 cells increased phospho-p190RhoGAP level. FAK siRNA knockdown in Grp78
overexpressing cells reversed phospho-p190RhoGAP level. These data suggested that Grp78 inhibited RhoA activity
by up-regulated phospho-p190RhoGAP level and Grp78 mediated p190RhoGAP phosphorylation is FAK dependent.
Conclusion: Grp78 promoted the invasion of hepatocellular carcinoma both in vitro and in vivo. Overexpression of
Grp78 in hepatocellular carcinoma cells enhanced the activation and activity of FAK which negatively regulated
Rock kinase activity by promoting the phosphorylation of p190RhoGAP.
Background
Hepatocellular carcinoma (HCC) is the fifth most com-
mon cancer of men and the eighth most cancer of
women worldwide, which causes 250, 000 deaths each
year[1,2]. Early HCC is clinically silent and often well
advanced at the first manifestation, only 10-20% of
patients are suitable for surgical treatment [2]. Even
having undergone surgical treatment, the prognosis of
patients with HCC is still poor [3]. The poor prognosis
is largely attributed to the invasion at early stage in
HCC. Thus there is a substantial need for exploring
novel treatments to prevent the invasion of HCC.
The glucose-regulated protein Grp78, a stress-induced
endoplasmic reticulum(ER) chaperone, is expressed at
basal levels in normal adult organs such as the brain,
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Overexpression of Grp78 in tumor cells has been linked
to the progression of many human cancers including
colon cancer, lung cancer, gastric cancer, breast cancer
etc [5-8]. Most of the previous studies have been focus-
ing on the roles of Grp78 in anti-apoptosis, chemother-
apy resistance in human cancers, but it remains unclear
whether Grp78 is involved in the regulation of tumor
invasion and metastasis [9].
Recent advances have revealed that Grp78 is asso-
ciated with the invasion and metastasis of many human
cancers. The elevated expression of Grp78 is associated
with increased lymphatic node metastasis in gastric can-
cer [10]. The concentration of Grp78 antibody in serum
samples of patients with prostate cancer is positively
correlated with the invasion potentiality of cancer cells
[11]. The expression level of Grp78 in cancer cells is a
biomarker for predicting the invasion and metastasis in
breast cancer [12].
Tumor invasion and metastasis is an integrated pro-
cess that requires the coordinated regulation of various
signaling molecules including some kinases and phos-
phatases. These kinases and phosphatases regulate
tumor invasion and metastasis by phosphorylation and
dephosphorylation of many signal molecules [13]. The
protein tyrosine kinase Focal adhesion kinase (FAK)
plays a prominent role in tumor invasion and metastasis
[14]. Enhanced FAK signaling promotes the invasion
and metastasis of cancer cells. The phosphorylation of
Y397 activates FAK and provides docking site for Src
kinase which contributes to maximal activity of FAK by
phosphorylation at Y576/577 of FAK. Rock kinase acts
downstream of FAK and plays critical roles in the inva-
sion of tumor cells. Although basal level of Rock activity
is essential for tumor invasion, overactivation of Rock
kinase inhibits tumor invasion [15].
In this article, we overexpressed Grp78 in human
hepatocellular carcinoma cells SMMC7721 and investi-
gated the effect of Grp78 overexpression on the invasion




10-day-old white Leghorn chick embryos were provided
by the Experimental Animal Center of Liaoning Medical
College. ECM-gel, protease inhibitors, TRITC-conjugated
phalloidin, and BCIP/NBT staining solution were pur-
chased from Sigma Corporation. Transwell was obtained
from Costar Corporation. Control RNA was obtained
from cell signaling Corporation. Fugene HD transfection
reagent was obtained from Roche Corporation. TransMes-
sengerTM transfection reagent was purchased from Qia-
gen Corporation. HRP/Fab Polymer conjugated secondary
antibodies were obtained from ZhongShan Company.
Rock dominant negative recombinant KDIA and Rhote-
kin-RBD bound to glutathione-S-transferase sepharose
beads were kindly given by Dr Chen Yu-Hua (Develop-
mental Biology Department, China Medical University).
Antibodies
Grp78, RhoA antibodies were purchased from Santa
Cruz Corporation. FAK-pY576/577 was the product of
cell signaling Corporation. FAK, FAK-pY397 was
obtained from Biosource Corporation. ALP-conjugated
secondary antibodies were purchased from cell signaling
Corporation.
Human tissue specimens
All 44 cases tissue samples of patients with HCC were
obtained from the Department of Gastroenterology of
the General Hospital of Chinese Liberation Army. The
Ethics Committee of Liaoning Medical College approved
and supervised specimen collection procedures. All the
experimental performances related to the tissue samples
were in compliance with Helsinki Declaration. We have
got the permissions of all the patients before specimen
collection. All clinicopathological data were retrospec-
tively collected by reviewing the patients’ medical charts.
The differentiation extents were re-evaluated by two
pathologists according to Edmondson-Steiner grading
system. None of the patients has received chemotherapy
or irradiation before surgery. Clinicopathological data
were summarized and listed in table 1.
Immunohistochemistry
Immunohistochemistry was performed on the formalin-
sixed paraffin sections. Briefly, 5 μm sections were
dewaxed, rehydrated and incubated in 0.3% (V/V)
hydrogen peroxide in PBS (0.01 M, pH 7.6) for 20 min
to inactivate endogenous peroxidase. Antigen was
retrieved by high pressure for 2 min in citrate buffer
(0.01 M sodium citrate, pH 6.0). The sections were then
incubated with 1:100 diluted primary antibodies at 4°C
overnight, and then stained with HRP/Fab Polymer con-
jugated secondary antibodies for 30 min at room tem-
perature. The antibodies were revealed by DAB at room
temperature for 1 min. The primary antibodies were
replaced by PBS as negative control. All sections were
examined and scored independently by two investigators
without any knowledge of the clinicopathological data of
the patients, at least 5 fields were randomly chosen.
Expressions of Grp78, FAK were evaluated according to
the ratio of positive cells per specimen and staining
intensity. The ratio of positive cells per field was evalu-
ated quantitatively and scored as 0 for staining less than
5%, 1 for staining of 5 to 10%, 2 for staining of 10 to
50%, 3 for staining >50%. Intensity was graded as fol-
l o w s :1 ,w e a k ;a n d2 ,s t r o n gs t a i n i n g .At o t a ls c o r eo f0
to 6 was calculated and the scores were designated as 1
(score: 0-1), 2 (2-4), and 3 (5-6).
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Human hepatocellular carcinoma cell line SMMC7721
was kindly given by Dr YH Chen (Developmental Biol-
ogy Department of China Mediacal University). The
cells were propagated in DMEM supplemented with
10% FBS, 2 mM glutamine, 100 U/ml penicillin, 100 μg/
ml streptomycin at 37°C, 5% CO2 -95% O2.
Transfection
Transfection was performed according to the instruction
of Roche’s Fugene HD protocol. Briefly cells were cul-
tured to 60-70% confluence in a six-well culture plate
and transfected with 4 μg plasmid using 16 μlF u g e n e
HD (1:4 ratios). As control, cells were transfected with
vectors under the same condition. Stable transfectants
Table 1 Clinicopathological data and the expressions of Grp78 and FAK of 44 patients with HCC
Number sex age HBsAg Grade FAK level Grp78 level Portal invasion Intrahepatic invasion
1. Male 63 + Well 1 1 N N
2. Male 49 - Well 1 1 N N
3. Male 45 - Well 1 1 N N
4. Male 64 + Well 1 1 N N
5. Male 68 + Well 1 1 N N
6. Female 69 + Well 2 2 N N
7. Male 63 + Well 1 2 N N
8. Female 32 - Well 3 3 Y N
9. Male 42 - Well 2 2 N N
10. Male 50 + Well 2 3 N N
11. Male 55 + Poorly 3 3 Y Y
12. Male 63 + Poorly 3 3 Y Y
13. Male 35 + Poorly 3 3 Y Y
14. Male 69 + Poorly 2 3 Y Y
15. Male 36 - Poorly 1 1 N N
16. Male 60 + Poorly 2 2 Y N
17. Male 48 + Poorly 2 2 N Y
18. Male 49 - Poorly 3 3 Y Y
19. Female 73 + Poorly 2 3 Y Y
20. Male 53 + Poorly 3 3 Y Y
21. Male 59 + Poorly 2 2 Y N
22. Male 66 + Poorly 3 3 Y Y
23. Male 33 - Poorly 1 1 N N
24. Male 37 - Poorly 3 3 Y Y
25. Female 67 + Poorly 1 1 N N
26. Male 60 + Poorly 2 3 Y Y
27. Male 43 + Poorly 2 2 N N
28. Male 42 - Poorly 3 3 Y Y
29. Female 54 - Poorly 3 3 Y Y
30. Female 58 + Poorly 2 2 N N
31. Female 41 - Poorly 3 3 Y Y
32. Male 31 - Moderately 1 1 N N
33. Male 39 - Moderately 2 2 Y N
34. Male 59 + Moderately 1 1 N N
35. Female 55 - Moderately 3 2 N Y
36. Male 32 - Moderately 1 1 N N
37. Female 42 - Moderately 3 3 N Y
38. Male 58 + Moderately 3 1 N N
39. Male 55 + Moderately 2 2 Y N
40. Male 45 - Moderately 3 3 Y N
41. Female 42 - Moderately 3 2 N N
42. Female 51 + Moderately 3 3 Y Y
43. Male 68 + Moderately 3 3 Y N
44. Male 57 + Moderately 3 3 N N
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ml G418 for 2-3 weeks. G418 resistant clones were iso-
lated and cultured in complete medium containing 200
μg/ml G418. The positive clones were identified by wes-
tern blot. The plasmids used in this experiment were
pcDNA3.1 (+)-Grp78 and Rock dominant negative
recombinant pCAG-KDIA. pcDNA3.1 (+)-Grp78 recom-
binant was constructed by inserting a 2 kb fragment of
human Grp78 cDNA into HindIII and XhoI site of
pcDNA3.1 (+) [16].
RNA interference
The siRNA sequences against Grp78 and FAK were
designed by siRNA finder (Ambion, USA), screened by
Ui-Tei K’s principles and synthesized by Genechem Cor-
poration (Shanghai, China) [17]. The sequences of sense
strands of siRNA duplex were as follows: Grp78: 5’-
AGACGCUGGAACUAUUGCUUU-3’,F A K :5 ’-GAUA-
GUGGACAGUCACAAAUU-3’. Cells in exponential
g r o w t hp h a s ew e r ep l a t e di n six-well plate (5 × 10
5
cells/well), allowed to adhere for 24 h and transfected
with siRNA. Transfection of siRNA was performed as
Qiagen’s TransMessengerTM Handbook. Briefly, the
cells were incubated for 4 h with the transfection com-
plex containing 4 μgs i R N A .A f t e r4h ,t h et r a n s f e c t i o n
complex was removed and the cells were incubated in
complete growth medium for 72 h. The effect of siRNA
transfection was confirmed by western blot.
Chick Embryo Metastasis Assay AND Alu PCR
The chick embryo metastasis assay was performed as
Quigley JP [18]. Briefly, 1 × 10
6 tumor cells were sus-
pended in 25 μl serum free medium and inoculated on
the chorioallantoic membrane (CAM) of 10-day-old
white Leghorn chick embryos. The embryos were incu-
bated in a stationary incubator for 7 days. After which
the embryonic lungs and livers were harvested and the
status of tumor invasion and metastasis were evaluated
by human specific Alu PCR using DNA extracts from
chick embryonic lungs and livers. Primers specific for the
human Alu were as follows: 5’-ACG CCT GTA ATC
CCA GCA CTT-3’ (sense), 5’-TCG CCC AGG CTG
GAG TGC A-3’ (antisense). Each PCR reaction was per-
formed in a final volume of 20 μl containing 60 ng of
genomic DNA, 2 mM MgCl2,0 . 4μM each primer, 200
μM dNTPs, 0.4 units of Taq polymerase for 30 cycles.
PCR cycling conditions were as follows: 95°C for 30 s, 63°
C for 30 s and 72°C for 30 s. Chick GAPDH was ampli-
fied at the same condition as internal control. The pro-
ducts were separated by 1% agarose gel and evaluated by
Chemi-Genius gel imaging and analysis system (UK)
Cell spreading
Cells were trypsinized, re-plated on fibronectin (10 μg/
ml) pre-coated coverslips (105 each well) and allowed to
spread for 1 h, 2 h respectively. The status of cell
spreading and polarity formation were photographed by
inverse microscopy and analyzed by Orisis software
HUG. Cell spreading was represented by the mean area
(pixels) and cell polarity formation was described as the
ratio of long axis/short axis.
Western blot
Cells were harvested, lysed in RIPA buffer (150 mM
NaCl, 1% NP-40, 1% SDS, 1 mM PMSF, 10 ug/ml leu-
peptin, 1 mM aprotinin, 50 mM Tris-Cl, pH 7.4) for 30
min. The protein concentration was determined by the
BCA assay. Cell lysate (50 μg each lane) were separated
by 10% SDS-PAGE, transferred to PVDF membrane.
The membrane was blocked with 5% non-fat milk for 1
h, incubated with 1:1000 diluted primary antibodies for
3 h, stained with 1:2000 diluted ALP-conjugated second-
ary antibodies for 30 min at room temperature. Bound
antibodies were revealed by BCIP/NBT staining. The
levels of interested proteins were analyzed by Chemi-
Genius gel imaging and analysis system (UK).
Fluorescence
Cells were harvested, replated on fibronectin pre-coated
coverslips (10 μg/ml). After 24 h, cells were fixed in
3.7% formaldehyde in PBS, permeabilized with 0.1% Tri-
ton X-100 in PBS, blocked with PBS containing 1%
BSA, incubated with TRITC-conjugated phalloidin for
30 min. The slides were mounted by 95% glycerol and
observed by ZEISS A-1 fluorescent microscope (Carl
ZEISS, Germany).
Transwell Assay
Transwell invasion assay was performed as Costar’s
Transwell procedure. Briefly, Cells were seeded to ECM
gel pre-coated, porous upper chamber inserts (5 × 10
4
each well) and allowed to invade for 12 h. After 12 h,
the inserts were inverted and stained with Hoch-
est33258. The numbers of invaded cells were observed
and counted using fluorescent microscope. Three fields
were randomly chosen and the numbers of penetrated
cells were counted.
RhoA activity assay
RhoA activity was determined by GST pull-down assay.
Briefly, the transfected cells were lysed in NP-40 lysis
buffer (150 mM NaCl, 1% NP-40,1 mM PMSF, 10 ug/
ml leupeptin, 1 mM aprotinin, 50 mM Tris-Cl, pH 7.4)
for 30 min, Cell lysates were centrifuged at 4°C at
14,000 g for 5 min to remove particulate material. The
protein concentrations were determined by the BCA
assay. Protein extracts (containing 50 μgo fp r o t e i n )
were incubated at 4°C for 1 h with an equal volume of
Rhotekin-RBD bound to glutathione-S-transferase
Sepharose beads on a rotator, centrifuged for 14,000 g
for 10 min. The pellets were separated by 10% SDS-
PAGE and transferred to PVDF membrane for Western
blot analysis using anti-RhoA as primary antibody. The
abundance of RhoA was quantified by Chemi-Genius gel
imaging and analysis system (UK).
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Comparison of the protein levels was performed using
one way ANOVA. The correlation analysis was per-
formed by spearman test. A P-value less than 0.05 was
considered statistically significant.
Results
The expression of Grp78 is positively correlated with
portal invasion and intra-hepatic invasion in patients with
hepatocellular carcinoma
To investigate Grp78 and FAK expressions in hepatocel-
lular carcinoma, immunohistochemical staining was per-
formed and the results were listed in table 1. As shown
in table 1 and table 2, Grp78 and FAK were expressed
at high levels in most of poorly differentiated tissue
samples (61.9%, 47.6%), and at relatively low levels in
most of moderately and well differentiated tissue sam-
ples (Fig. 1). Spearman test indicated that Grp78 and
FAK expression levels were negatively correlated with
the differentiation extent of HCC(r = 0.37, P =0 . 0 1 ;r=
0.312, P = 0.04).
The status of the portal invasion and intra-hepatic
invasion of 44 patients with hepatocellular carcinoma
were also listed in table 1. The correlation between
Grp78 expression and the status of portal invasion and
intra-hepatic invasion of 44 patients with HCC were
analyzed by Spearman test. As shown in table 3, the
expression levels of Grp78 were positively correlated
with portal invasion and intra-hepatic invasion in 44
patients with HCC (r = 0.724, P = 0.00; r = 0.679, P =
0.00). The statistical analysis also revealed a positive cor-
relation between Grp78 and FAK levels in 44 tissue
samples of HCC (Table 4).
Grp78 promoted the invasion of hepatocellular carcinoma
cells
To confirm our previous results, we transfected
SMMC7721 cells with pcDNA 3.1(+)-Grp78 recombi-
nant by Fugene HD followed by G418 selection. The
transfection efficiency was assessed by western blot,
indicating a significant increase (= 2.5 fold) as compared
with mock-transfected cells (Fig.2A).
We examined the invasion of Grp78 overexpressing
cells by transwell assay in vitro and chick embryo
metastasis model in vivo respectively. Transwell assay
revealed that SMMC7721 cells stably overexpressing
Grp78 showed a significant increase in invasion (> 2
fold) as compared with mock-transfected cells (Fig. 2B).
Chick embryo metastasis and Alu-PCR indicated a sig-
n i f i c a n ti n c r e a s ei ni n v a s i o ni nG r p 7 8o v e r e x p r e s s i n g
cells (≈3 fold) over mock-transfected cells (Fig. 2C).
To confirm that the increased invasion of Grp78
transfected cells is caused by Grp78 itself, Grp78 level
in Grp78 overexpressing cells was knockdown by siRNA
transfection (Fig. 2D). We found that the increased inva-
sion of Grp78 overexpressing cells was significantly
inhibited (Fig. 2E). Taken together, these data suggested
that overexpression of Grp78 promoted the invasion of
hepatocellular carcinoma cells.
Grp78 promoted cell spreading and cell polarity
formation of hepatocellular carcinoma cells
To determine if Grp78 affected the spreading of tumor
cells, we observed the spreading status of Grp78 overex-
pressing cells for 2 h after the cells were replated on
fibronectin-coated coverslips (10 μg/ml). We found that
Grp78 overexpressing cells exhibited an accelerated
spreading as compared with mock-transfected cells.
Most Grp78 overexpressing cells exhibited a polar, elon-
gated, morphology after 2 h of replating. However
mock-transfected cells presented a round symmetric
morphology without obvious polarity formation (fig 3A).
The status of cell spreading and cell polarity formation
was analyzed using Osiris software (HUG). The extent
of cell spreading was depicted as the mean area of
tumor cells. We found that the mean area of Grp78
overexpressing cells was 14971 ± 1929 pixels after 2 h
of replating on fibronectin -coated surface. By contrast,
the mean area of mock-transfected cells was 8234 ±
1905 pixels, indicating that overexpression of Grp78
promoted the spreading of tumor cells (Fig. 3B).
The extent of cell polarity formation of Grp78 overex-
pressing cells was represented as the ratio of long axis
and short axis. The results revealed that the mean value
of Grp78 overexpressing cells was 1.5 ± 0.07, indicating
an asymmetric, elongated morphology. The mean ratio
of mock-transfected cells was 1.1 ± 0.06, suggesting a
symmetric, round morphology (Fig.3C).
We also observed obvious lammellipodia formation in
Grp78 overexpressing cells. Cell monolayer was carefully
wounded by sterile pipette and the morphology of the
cells at the wound edge was observed. Grp78
Table 2 The expression of Grp78 and FAK is negatively correlated with the grade of HCC.
Grp78 FAK
Grade 1 2 3 rP 123 rP
Well 5(11.4%) 3(6.8%) 2(4.5%) 6(13.6%) 3(6.8%) 1(2.3%)
Moderately 4(9.1%) 4(9.1%) 5(11.4%) 0.37 0.01 3(6.8%) 2(4.5%) 8(18.2%) 0.31 0.039
Poorly 3(6.8%) 5(11.4%) 13(29.5%) 3(6.8%) 8(18.2%) 10(22.7%)
Total 12(27.3%) 12(27.3%) 20(45.4%) 12(27.3%) 13(29.5%) 19(43.2%)
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brane ruffles at leading edge, while the membrane ruf-
fles was not obvious in mock-transfected cells (Fig. 3D).
Overexpression of Grp78 enhanced the phosphorylation
of FAK in hepatocellular carcinoma cells
FAK is known to be an important intracellular signaling
molecule that regulates tumor cells invasion. It is known
that phosphorylation of Y397 of FAK results in its acti-
vation. We therefore reasoned that if overexpression of
Grp78 affected FAK activation. Grp78 overexpressing
cells showed a significant increase in pY 397 level (>2
fold) over mock-transfected cells, suggesting that over-
expression of Grp78 induced FAK activation (Fig. 4A).
We also found that the expression of FAK in Grp78
overexpressing cells was equal to mock-trandfected cells.
Phosphorylation of Y576/577 is essential for maximal
activity of FAK. We next examined pY576/577 level of
FAK in Grp78 overexpressing cells. As compared with
mock-transfected cells, a significant increase of pY576/
577 level (>2 fold) was found in Grp78 overexpressing
cells, indicating that overexpression of Grp78 promoted
the maximal activity of FAK (Fig. 4A).
To confirm the role of Grp78 in the activation and
activity of FAK, Grp78 level in Grp78 overexpressing
cells was knockdown by siRNA transfection, pY397 and
p Y576/577 levels were examined. We found that Grp78
siRNA knockdown in Grp78 overexpressing cells signifi-
cantly decreased pY397 and p Y576/577 levels of FAK,
indicating that the enhanced activation and activity of
FAK in Grp78 overexpressing cells was caused by Grp78
itself (Fig. 4B).
To further elucidate the role of FAK in Grp78 mediated
tumor cells invasion, we knockdown FAK in Grp78 over-
expressing cells and examined if FAK knockdown
Figure 1 Immunostaining of Grp78 and FAK in the tissue samples of HCC. (a-d), HE staining of the tissue samples of HCC. (a), poorly
differentiated tissue sample. (b), moderately differentiated tissue sample. (c) Well differentiated tissue sample. (d), peri-cancer tissue sample. (e-l),
Grp78 and FAK expressions in poorly differentiated tissue sample (e, i), moderately differentiated tissue sample (f, j), well differentiated tissue
sample (g, k) and peri-cancer tissue sample (h, l). (Scale bar = 25 μm).
Table 3 Correlation between Grp78 level and the status of portal invasion and intrahepatic invasion in 44 patients
with HCC.
Portal invasion Intrahepatic invasion
Grp78 level Y N r P YN r P
1 0(0.0%) 12(27.3%) 0(0.0%) 12(27.3%)
2 4(9.1%) 8(18.2%) 0.724 <0.01 2(4.5%) 10(22.7%) 0.679 <0.01
3 17(38.6%) 3(6.8%) 15(34.1%) 5(11.4%)
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found that the increased invasion of Grp78 overexpres-
sing cells was reversed to the level of mock-transfected
cells, suggesting that Grp78 regulated tumor cells inva-
sion in a FAK-dependent manner (Fig. 4C).
Overexpression of Grp78 negatively regulates Rock
activity
Rho dependent kinase (Rock), a downstream Rho effec-
tor, plays critical roles in the regulation of tumor inva-
sion. Overactivation of Rock restrains tumor invasion
and metastasis by promoting stress fiber formation and
stiffening the cell cortex [19,20]. We therefore deter-
mined if overexpression of Grp78 affected RhoA activity.
Grp78 overexpressing cells showed a significant reduc-
tion of RhoA-GTP level (>2 fold) as compared with
mock-transfected cells, suggesting that overexpression of
Grp78 inhibited RhoA activity (fig 5A).
To validate the inhibitory effect of Grp78 on RhoA
activity, we down-regulated Grp78 expression in Grp78
overexpressing cells by siRNA transfection. Interestingly,
Grp78 siRNA knockdown in Grp78 overexpressing cells
resulted in a significant increase (≈2.3 fold) in RhoA
-GTP level (Fig 5B).
To further validate the effect of Grp78 on Rock activity,
we down-regulated Grp78 level in cells stably expressing
KDIA, a Rock dominant negative recombinant which
inactivates endogenous Rock activity [21,22]. Grp78
siRNA knockdown KDIA transfected cells formed
obvious stress fibers in cell cortex. By contrast, actin
Table 4 Correlation between Grp78 and FAK expressions
in 44 patients with HCC.
FAK level
Grp78 level 1 2 3 r P
1 6(13.6%) 2(4.5%) 4(9.1%)
2 2(4.5%) 6(13.6%) 4(9.1%) 0.482 0.001
3 0(0.0%) 5(11.4%) 15(34.1%)
Figure 2 Overexpression of Grp78 induces hepatocellular carcinoma cells invasion. (A), Western blot of protein lysates from mock- and
Grp78-transfected SMMC7721 cells, indicating Grp78 expression level. The lower blot was used as loading control. (B), A transwell assay using
mcok- and Grp78-transfected cells was performed on inserts pre-coated with ECM gel. Images are representative of the invasion of Grp78
overexpressing cells in three separate experiments performed in triplicate. (C), A chick embryo metastasis assay was performed using mock- and
Grp78-transfected cells suspended in PBS. The extent of tumor cell invasion was evaluated by human specific Alu PCR using DNA extracts from
chick embryonic lungs and livers. Negative control: DNA extracts from untreated 7-day chick embryonic lungs and livers. Positive control: DNA
extracts from human colorectal caricinoma. (D), Western blot analysis showing Grp78 level in Grp78 siRNA and control siRNA transfected Grp78
overexpressing cells. (E) Representative image of a transwell assay using Grp78 siRNA knockdown Grp78 overexpressing cells and control siRNA
transfected Grp78 overexpressing cells for further elucidating the role of Grp78 in tumor cells invasion. The experiments were repeated for three
times in triplicate.
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transfected cells (fig 5C). We also found that Grp78
siRNA knockdown in KDIA transfected cells rescued the
invasion defect phenotype, suggesting that Grp78 knock-
down activated endogenous Rock activity (Fig. 5D).
Overexpression of Grp78 promotes p190RhoGAP
phosphorylation in a FAK-dependent manner
Previously, we have demonstrated that Grp78 enhanced
FAK phosphorylation and inhibited RhoA activity in
hepatocelluar carcinoma cells. We further reasoned how
Grp78 regulated Rock kinase activity. We found a signif-
icant increase of phospho-p190RhoGAP level in Grp78
overexpressing cells, suggesting that Overexpression of
Grp78 enhanced the phosphorylation of p190RhoGAP
(Fig. 6A). To explore if Grp78 enhanced the phosphory-
lation of p190RhoGAP in a FAK dependent manner,
FAK level in Grp78 overexpressing cells was down-regu-
lated by siRNA transfection, the phosphorylation status
of p190RhoGAP was determined (Fig. 6B). We found a
significant reduction of phospho-p190RhoGAP level in
FAK siRNA knockdown Grp78 overexpressing cells as
compared with mock-transfected cells, suggesting that
Grp78 promoted p190RhoGAP phosphorylation in a
FAK dependent manner (Fig. 6C).
Discussion
Grp78 is a stress-inducible protein which is ubiquitously
expressed in animal cells. Compared with normal tissue,
the expression of Grp78 in many human cancers is
strongly up-regulated. Grp78 is implicated in the onco-
genesis, progression, drug resistance of cancer cells.
Although the emerging importance of Grp78 in tumor
Figure 3 Overexpression of Grp78 promotes the spreading and cell polarity formation of hepatocellular carcinoma cells.( A ) ,
SMMC7721 cells that stably transfected with Grp78 or mock transfected were allowed to spread on Fibronectin (10 μg/ml) pre-coated surface
for 2 hours. The extent of cell spreading was photographed under phase-contrast microscopy at 1 hour and 2 hours. This experiment was
repeated for three times in triplicate. (Scale bar = 20 μm) (B), Overexpression of Grp78 in SMMC7721 cells promoted cell spreading which is
represented as the mean area of cells (pixels). (C), Overexpression of Grp78 in SMMC7721 cells promotes cell polarity formation which is
depicted as the ratio of long axis and short axis. (D) SMMC7721 cells that stably transfected with Grp78 form obvious thin, transparent
lamellipodia at the wound edge compared with mock-transfected cells.
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the data in hepatocellular carcinoma is still fewer. We
found a negative correlation between Grp78 level and
the portal invasion and intra-hepatic invasion in patients
with hepatocellular carcinoma, suggesting that Grp78 is
involved in the invasion of hepatocellular carcinoma.
This conlusion was in agreement with the data in other
human cancers.
Invasion of cancer cells to adjacent tissues is an essen-
tial characteristic of tumor progression which is tightly
regulated by many signaling molecules. Herein, we
found that overexpression of Grp78 in hepatocellular
carcinoma cells caused a two to three fold increase in
the invasion capability. Moreover, Grp78 siRNA knock-
down in Grp78 overexpressing cells reversed the higher
invasion capability near the level of control cells. Pre-
vious studies have linked Grp78 knockdown to the
decreased invasion capability of cancer cells in breast
cancer, gastric cancer and prostate cancer. Our results
revealed that Grp78 overexpression induced the invasion
of hepatocellular carcinoma.
Although the inhibitory roles of Grp78 knockdown in
tumor invasion have been reported in many human can-
cers, the molecular mechanism remains obscure. These
observations raised an issue. How Grp78 might induce
the invasion of cancer cells? Our results preliminarily
demonstrated that two major mechanisms are involved
in the increased invasion mediated by Grp78: enhance-
ment of FAK activation, inhibition of RhoA activity.
FAK is a key member of integrin-mediated signaling
pathways and plays critical roles in the adhesion, inva-
sion and migration [23]. Increased activation of FAK is
associated with more invasive and aggressive phenotypes
[24]. We found that overexpression of Grp78 in hepato-
cellular carcinoma cells increased FAK pY397 level sug-
gesting that Grp78 may be involved in the regulation of
Figure 4 Overexpression of Grp78 up-regulates FAK activation. (A), Western blot of phosphorylated Tyr 397 and Tyr 576/577 from serum
starved mock-transfected cells and Grp78-transfected cells plated on Fibronectin for 1 hour. Corresponding total FAK is shown in the lower blot.
(B), Western blot of phosphorylated Tyr 397 and Tyr 576/577 from serum starved Grp78 siRNA and control siRNA transfected Grp78
overexpressing cells plated on Fibronectin for 1 hour. (C), Representative image of a transwell assay using FAK siRNA and control siRNA
transfected Grp78 overexpressing cells for investigating the effect of FAK siRNA knockdown in Grp78 overexpressing cells on Grp78 mediated
tumor cells invasion. The experiments were repeated for three times in triplicate.
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Page 9 of 12FAK activation. This result was confirmed by the fact
that Grp78 siRNA knockdown in Grp78 overexpressing
cells caused a significant decreased FAK activation. We
also found that FAK siRNA knockdown in Grp78 over-
expressing cells partially inhibited the increased invasive
capabilities caused by Grp78, suggesting that FAK is
involved in Grp78 mediated tumor invasion. It is note-
worthy that the expression of FAK was unchanged in
Grp78 overexpressing cells compared with mock trans-
fected cells, suggesting the promotion role of Grp78 on
FAK activation was mainly by modulating the phosphor-
ylation of FAK.
Basal level RhoA activity is essential for the invasion
and metastasis of cancer cells. However, overactivation
of RhoA inhibits this process [25]. Many data have
revealed that RhoA is a downstream effector of FAK
which negative regulates the activity of RhoA. We found
that RhoA-GTP level in Grp78 overexpressing cells is
relatively lower than mock transfected cells. Moreover,
Grp78 siRNA knockdown in Grp78 overexpressing cells
significantly increased RhoA-GTP level, suggesting that
Grp78 may negatively regulate RhoA activity. This
conclusion is further confirmed by Grp78 siRNA knock-
down in Rock kinase dead cells which is transfected
with KDIA, a Rock dominant negative recombinant. We
observed obvious stress fiber formation in Grp78 siRNA
knockdown KDIA transfected cells and partially rescue
of the invasion ability, suggesting that overexpression of
Grp78 activated endogenous Rock. This conclusion is in
agreement with the previous studies that FAK is a nega-
tive regulator of RhoA activity in many human cancers.
Although the functional connection between FAK and
RhoA has been reported in many human cancers, how
Grp78 inhibited Rock activity in hepatocellular carci-
noma should be elucidated. We found that the RhoA-
GTP level in FAK siRNA knockdown Grp78 overexpres-
sing cells is significantly higher than in Grp78 overex-
pressing cells, suggesting that Grp78 promoted RhoA
activity by a FAK dependent manner.
p190RhoGAP is a member of GTPase activating pro-
teins which stimulate the GTPase activity on RhoGT-
Pase and hydrolyzed RhoA-GTP [15]. We observed that
increased phosphorylation level of p190RhoGAP in
Grp78 overexpressing cells. However, FAK siRNA
Figure 5 Overexpression of Grp78 decreases Rock activity in hepatocellular carcinoma cells. (A), lysates from mock- and Grp78 transfected
cells were precipitated using Rhotekin-RBD bound sepharose beads and blotted with anti-RhoA. Corresponding total RhoA is shown in lower
blot. (B), A GST pulldown assay using lysates from Grp78 siRNA and control siRNA transfected Grp78 overexpressing cells, indicating RhoA-GTP
level. (C), Grp78 knockdown in Rock dominant negative recombinant (KDIA) transfected cells caused obvious stress fiber formation, indicating
endogenous Rock activation. (Scale bar = 10 μm). (a), mock-transfected cells.(b) KDIA transfected cells. (c) Control siRNA transfected KDIA cells.
(d), Grp78 siRNA knockdown KDIA cells. (D), Representative image of a transwell assay using Grp78 siRNA and control siRNA transfected KDIA
cells, indicating Grp78 knockdown rescued the invasion of KDIA cells. The experiments were repeated for three times in triplicate.
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level of p190RhoGAP. These data suggested that
p190GAP may play important role in the connection
between FAK and RhoA in Grp78 mediated tumor
invasion.
Conclusion
Taken together, Grp78 promoted the invasion of hepa-
tocellular carcinoma both in vitro and in vivo.
Overexpression of Grp78 in hepatocellular carcinoma
cells enhanced the activation and activity of FAK which
negatively regulated Rock kinase activity by promoting
the phosphorylation of p190RhoGAP.
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